Skip to main content
Clinical Trials/NCT04689139
NCT04689139
Completed
Not Applicable

Role of Intraoperative Biomarkers in Prognosis of Perioperative Complications in Reconstructive Thoracic Aorta Surgery

Petrovsky National Research Centre of Surgery1 site in 1 country132 target enrollmentMarch 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Aneurysm
Sponsor
Petrovsky National Research Centre of Surgery
Enrollment
132
Locations
1
Primary Endpoint
Number of Total Postoperative Complications
Status
Completed
Last Updated
last year

Overview

Brief Summary

Biomarkers can play a vital role in prognosing the perioperative complications in thoracic aorta surgery. The goal of a study is to determine the correlation between intraoperative level of certain biomarkers and total amount of peroperative complications.

Detailed Description

This study aims to assess the association between levels of biomarkers and postoperative complications in patients after thoracic and thoracoabdominal aortic reconstruction.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
May 1, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Petrovsky National Research Centre of Surgery
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Elective thoracic and thoracoabdominal surgery

Exclusion Criteria

  • Hemolysis in blood sample

Outcomes

Primary Outcomes

Number of Total Postoperative Complications

Time Frame: up to 10 days

Value reported in the Outcome Measure data table reflects the Number of Total Postoperative Complications across all participants.

Secondary Outcomes

  • Number of Participants Who Require Extracorporeal Detoxication(up to 10 days)
  • Number of Infections and Infestations(up to 10 days)
  • Total Number Affected by All-Cause Mortality(up to 10 days)
  • Number of Vascular Disorders(up to 10 days)
  • Number of Cardiac Disorders(up to 10 days)

Study Sites (1)

Loading locations...

Similar Trials